Follow Yahoo Finance
Quotes you view appear here for quick access.
Use comma (,) to separate multiple quotes.
Business & Finance
Isis Pharmaceuticals initiated with a Neutral at JPMorgan
October 4, 2013 6:20 AM
Health Care Industry
Click to view comments
View Comments (
Scary October start for stocks; Russell in correction
G.M. outlines plan to increase profit margins
Dollar gains could bode well for large caps
Coca-Cola revises executive pay after criticism
Ford's warning to the world
Isis Pharmaceuticals, Inc.
11:24 AM EDT
7:01 am ISIS Pharm earns $1.5 mln from GSK (<a href="/q?s=gsk" name="gsk">GSK</a>) for the advancement of ISIS-GSK4 Rx to treat an undisclosed ocular disease.
1 day 4 hrs ago
5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential
24/7 Wall St.
7 days ago
Looking to Save Money on Home & Auto Insurance?
David Nelson, CFA
Line in the Sand for the S&P 500
Dragonflies Watching Prices
A Band-Aid for your Portfolio: Johnson & Johnson
The best and worst outcomes for the Hong Kong protesters
U.S. oil heads to S. Korea as global supply increases & prices slide
Cisco slashes CEO pay after missed goals
Bridgewater: Inside the secretive world of the world’s biggest hedge fund
Amazon settling Disney DVD dispute won't resolve book stand-off
Chris Ciovacco's Tumblr
Will Buyers Step Up Again?
More Top News »
More Market News
Wayfair Surges After $319M IPO, Lock-up Fells GoPr …
Does BofA’s Moynihan Deserve His Chairman Title?
Cashin: Market technically oversold
U.S. Stocks Waver at the Opening Bell on ECB, Earnings …